fincash logo SOLUTIONS

Fincash » Search » Cadila Healthcare Ltd

Cadila Healthcare Ltd

Updated on July 8, 2020

Stock/Share Code - CADILAHC

Cadila Healthcare is one of the leading, innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovation (research & development), manufacturing, more

Below is the details of CADILAHC Cadila Healthcare Ltd

Market Cap₹35,278 Cr.
Current Price ₹353.8 as on 14 Jul 20
52 Week High / Low Price₹378 / ₹202
Face Value₹1
Stock P/E28.22
Book Value₹90.85
Dividend Yield1.02 %
ROCE16.98 %
ROE18.28 %
Sales Growth (3yrs)-2.62 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has been maintaining a healthy dividend payout of 34.91%
Cons: Stock is trading at 3.79 times its book value The company has delivered a poor growth of 9.94% over past five years. Tax rate seems low Earnings include an other income of Rs.519.90 Cr.

Cadila Healthcare Ltd Price Chart

Cadila Healthcare Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹164.15 28.53 ₹113,788.46 Cr. 0.63 ₹399.84 Cr. -2.03 14.25 8184.94 11.19
2. Dr Reddy's Labs ₹3,983.15 33.39 ₹67,652.81 Cr. 0.49 ₹781.1 Cr. 71.52 10.41 4448.90 12.42
3. Cipla ₹632.3 33.79 ₹52,256.4 Cr. 0.46 ₹245.95 Cr. -33.02 -0.63 4376.19 10.94
4. Aurobindo Pharma ₹809.35 16.67 ₹43,690.51 Cr. 0.40 ₹705.45 Cr. -2.26 11.87 5895.00 18.45
5. Biocon ₹437.6 62.53 ₹42,564 Cr. 0.14 ₹123.4 Cr. -42.26 3.41 1581.00 13.39
6. Torrent Pharma. ₹35.95 39.00 ₹39,979.07 Cr. 0.72 ₹314 Cr. 121.13 4.85 1946.00 12.66
7. Cadila Health. 28.22 ₹35,278.17 Cr. 1.02 ₹281.6 Cr. -22.49 10.33 1848.60 16.98
8. Alkem Lab ₹2,474.9 24.26 ₹27,056.36 Cr. 0.97 ₹381.98 Cr. 88.60 13.26 2181.84 16.58

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Cadila Healthcare Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Sales -8201,0431,7381,5741,4551,5051,6441,6761,6681,3441,6831,849
YOY Sales Growth %-42.58%12.91%138.58%107.52%77.41%44.33%-5.40%6.46%14.62%-10.71%2.32%10.33%
Expenses -7598441,0881,1491,0821,1211,1351,2191,2621,1611,2171,433
Material Cost %33.26%29.34%29.21%28.89%29.38%35.56%31.44%32.07%33.48%34.41%29.33%34.01%
Employee Cost %19.08%17.74%11.40%12.85%16.02%15.83%14.79%14.32%15.17%19.74%15.89%15.02%
Operating Profit61198650424373384509456406183466416
OPM %7%19%37%27%26%25%31%27%24%14%28%22%
Other Income4055267434610641050462740839
Profit before tax41517262338731536879143233894713322
Tax %-14%47%28%21%23%16%16%16%23%16%12%12%
Net Profit4719145030624331066636326279628282
EPS in Rs4.600.894.392.992.383.036.513.552.560.776.132.75

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -1,6431,6981,8332,9203,1513,5274,0425,2847,0323,2315,8106,4936,543
Sales Growth %16.22%3.40%7.91%59.33%7.89%11.95%14.59%30.73%33.07%-54.06%79.83%11.75%
Expenses -1,4111,5341,7992,2112,4832,8203,2333,7504,4542,9094,1644,7385,072
Material Cost %38.47%38.26%41.90%29.79%32.91%35.93%35.01%31.25%26.90%31.22%29.19%33.08%
Manufacturing Cost %6.10%6.38%7.40%6.33%10.40%11.25%10.21%8.57%5.70%10.59%8.25%8.29%
Employee Cost %11.34%11.61%14.57%15.39%14.44%12.43%13.50%11.98%10.33%20.20%14.25%15.05%
Other Cost %29.98%34.08%34.30%24.22%21.05%20.34%21.27%19.16%20.41%28.03%19.97%16.55%
Operating Profit232164347096687078091,5342,5783221,6461,7551,471
OPM %14%10%2%24%21%20%20%29%37%10%28%27%22%
Other Income1593036205723752307185174582208612520
Profit before tax2742965206376705319461,4652,5046421,4971,9281,467
Tax %14%10%3%4%2%6%4%13%19%-3%27%17%
Net Profit2362665036106584999041,2712,0386621,0911,6021,250
EPS in Rs2.412.504.815.826.254.878.8211.9719.906.4510.6515.6512.21
Dividend Payout %24%23%14%21%23%31%20%19%16%50%33%22%

Compounded Sales Growth

  • 10 Years:: 14.35%
  • 5 Years:: 9.94%
  • 3 Years:: -2.62%
  • TTM:: 4.19%

Compounded Profit Growth

  • 10 Years:: 18.93%
  • 5 Years:: 11.01%
  • 3 Years:: -9.19%
  • TTM:: -21.03%

Return on Equity

  • 10 Years:: 10.71%
  • 5 Years:: -1.39%
  • 3 Years:: -11.32%
  • 1 Year:: 38.95%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital -636868102102102102102102102102102102
Equity Capital636868102102102102102102102102102
Other Liabilities -4985256558089128551,0271,3621,4241,4891,5461,4381,555
Trade Payables235278374346285361462671900996803664682
Advance from Customers43447810208678
Other liability items260243276458620486556672516488735766874
Total Liabilities2,2912,5772,8713,4624,7545,5526,2437,3378,92311,04712,16413,49213,791
Fixed Assets -7848379501,0371,2181,4971,5641,7682,1552,3522,6803,0092,968
Gross Block1,2411,3581,5571,7322,0162,5112,6843,1193,7203,8964,5165,159
Accumulated Depreciation4385025866767981,0141,1201,3511,5661,5441,8362,150
Other Assets -9681,0281,1791,4932,0122,3112,5912,9934,1544,0935,2065,1735,185
Trade receivables2823524014756166837221,0561,7079291,2552,0881,906
Cash Equivalents19262842118928912916417184106174
Loans n Advances357334402210272305378331294404865625757
Other asset items-22-33-333015056457376731,3321,8101,582943850
Total Assets2,2912,5772,8713,4624,7545,5526,2437,3378,92311,04712,16413,49213,791

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -422685865603724458781,0841,954867288629
Profit from operations3483916227346236668641,5762,6503051,6971,783
Loans Advances000-38-61-28-32130000
Interest paid-30-550000000000
Direct taxes-14-23-26-63-23-6822-197-414-112-295-321
Other operating items000-15088-10616-411756-375212
Exceptional CF items-5-382908000-2400
Cash from Investing Activity --267-267-249-368-817-709-408-577-1,016-2,48028-526
Fixed assets purchased-168-175-232-303-378-542-282-304-573-777-602-658
Fixed assets sold112421852322435
Investments purchased-151-152-53-100-706-136-285-388-154-1,5560-14
Investments sold013401970210165710339
Interest received007415112227638310292
Dividends received4040365221134272140040150387
Loans to subsidiaries00-102-40-162-134-285-56-414-1,631-227-398
Acquisition of companies0000000000-360-1,373
Other investing items0-66020561243429923531,093
Cash from Financing Activity -2326-335-178522250-446-387-9231,366-149-180
Proceeds from borrowings29172219678836933293041011,929320357
Repayment of borrowings00-444-97-162-194-529-440-328-212-416-95
Interest paid fin00-38-33-56-74-73-39-18-22-53-83
Dividends paid-50-56-62-102-128-153-153-184-573-3270-358
Other financing items-8-10-10-12-15-22-20-27-106-20-1
Net Cash Flow7731476-142512014-247167-78

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %21%20%27%28%24%15%20%27%38%8%15%17%
Debtor Days63768059717165738910579117
Inventory Turnover4.985.005.026.916.536.486.467.209.624.065.164.75

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Cadila Healthcare Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.